Another great management decision
Can hardly wait to hear the spin as to we have multiple options for providers as we now have a direct competitor to the oral market
News flash oral t has no market share

Nocdurna 2.0
Have we not learned anything?
So let’s take Jatenzo’s 0.7% market share
Along with Xyosted’s 3.25%
2-4 in 2022
Oh wait my bad I forgot Xyosted has great coverage

So many people got Covid at the NSM and Joe Renda showed his true colors in his response. No empathy whatsoever; no regard for people’s families. Time to start looking.